Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
583 participants
OBSERVATIONAL
2024-07-13
2025-09-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Outcomes of Postpartum Hemorrhage in Patients Undergoing Cesarean Delivery
NCT04833556
Incidence of Complications Associated With Anesthesia in Obesity Parturient Undergoing Cesarean Delivery
NCT04657692
Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery
NCT02846129
Reducing Postpartum Hemorrhage After Vaginal Delivery
NCT05501106
Coagulation Factor Changes Associated With Postpartum Hysterectomies
NCT00456547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Obstetric Comorbidity Index has undergone thorough examination and validation across multiple nations. These findings collectively demonstrate the index's capacity for moderate to high predictive accuracy in anticipating maternal morbidities, accompanied by a commendable discriminative performance.
However, within the context of Thailand, investigations concerning the Obstetric Comorbidity Index and its association with perioperative complications or morbidities in postpartum hemorrhage patients undergoing cesarean delivery remain unexplored. Therefore, this study aims to elucidate the correlation between the Obstetric Comorbidity Index and severe maternal morbidity, while also scrutinizing the prevalence of comorbidities during the perioperative period among patients undergoing cesarean delivery at the largest University hospital, in THAILAND. Predicting the rate of maternal morbidity would be advantageous for facilitating preparation and augmenting awareness of complications during the perioperative period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with postpartum hemorrhage with severe maternal morbidity
Patients with either one of severe maternal morbidity (severe hemorrhage, hypertension/neurologic, renal, sepsis, pulmonary, cardiac, intensive care unit, and anesthesia complications)
Obstetric comorbidity index
Obstetric comorbidity index score
Patients with postpartum hemorrhage without severe maternal morbidity
Patients without the severe maternal morbidity conditions
Obstetric comorbidity index
Obstetric comorbidity index score
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Obstetric comorbidity index
Obstetric comorbidity index score
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* A patient chart that does not contain primary outcome data eg. absence of anesthetic record
* Blood loss less than 1,000 ml in the first 24 hours postpartum
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patchareya Nivatpumin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok THAILAND
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Siriraj Hospital
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Si 359/2024
Identifier Type: OTHER
Identifier Source: secondary_id
351/2567(IRB2)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.